QAPI Program Failed to Track Psychotropic Medication Oversight
Summary
The facility failed to maintain an effective, ongoing QAPI program for high-risk and problem-prone areas related to psychotropic medication management and oversight. During interviews, the DON stated that residents receiving as needed psychotropic medications were supposed to be reassessed by the physician every 14 days for renewal, but the pharmacy was not tracking those renewals consistently and there was no process in place before July 2025 to monitor medications requiring 14-day renewals. She also stated that some as needed psychotropic medication stop dates were entered as indefinite, some residents continued receiving these medications beyond 14 days, and the facility had no psychotropic medication policy available for review. The DON further stated that a psychotropic risk assessment tool was not used routinely to monitor adverse side effects, and that the TAR notation to monitor for side effects was not an assessment. She confirmed that AIMS assessments were only completed when recommended by the consultant pharmacist and that psychotropic medication consent forms were not completed or updated for multiple residents receiving psychotropic medications. The MDS nurse/ADON also stated that she did not complete AIMS assessments during MDS assessment time frames and agreed that such assessments should be completed for residents on psychotropic medications. The facility’s QAPI process did not show a clear performance improvement plan for these issues. Review of the QAPI binders showed no clear PIP plan, no documented process or expected improvement outcomes for the identified concerns, missing committee member reports in various months, and no clear process to measure improvement outcomes. The DON stated that the QAPI committee had not implemented a PIP into the QAPI process, that she was auditing nurse documentation as part of a PIP but did not record the necessary information to identify results, and that she did not report her information at the scheduled monthly QAPI meetings. She also stated that no board member was assigned to review and acknowledge facility policies and procedures or oversee the QAPI program. The physician agreement and QAA policy showed that the physician was expected to participate in the QA committee and that the committee was to meet monthly and review outstanding QAPI plans, but the survey findings showed no active physician guidance regarding the 14-day psychotropic stop-date requirement and no documented board oversight of the QAPI program.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.